[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Brischetto et al., 2020 - Google Patents

Testing for COVID-19

Brischetto et al., 2020

View HTML
Document ID
17764501161722129340
Author
Brischetto A
Robson J
Publication year
Publication venue
Australian Prescriber

External Links

Snippet

Testing for COVID-19 - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now. Search PMC …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/5695Mycobacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56916Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988AIDS or HTLV
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases

Similar Documents

Publication Publication Date Title
Scohy et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis
Lai et al. Laboratory testing for the diagnosis of COVID-19
World Health Organization Advice on the use of point-of-care immunodiagnostic tests for COVID-19: scientific brief, 8 April 2020
Zhang et al. Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing
Cho et al. Evaluation of five rapid diagnostic kits for influenza A/B virus
Aoki et al. Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2
Lim et al. Current laboratory diagnosis of coronavirus disease 2019
Bailey et al. Canadian society of clinical chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serology
Jia et al. False negative RT-PCR and false positive antibody tests–concern and solutions in the diagnosis of COVID-19
Abusrewil et al. Time scale performance of rapid antigen testing for SARS‐CoV‐2: Evaluation of 10 rapid antigen assays
Brischetto et al. Testing for COVID-19
Gulholm et al. Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2
Verma et al. Rapid diagnostic methods for SARS-CoV-2 (COVID-19) detection: an evidence-based report
Flores et al. Performance of ANTI‐HCV testing in dried blood spots and saliva according to HIV status
Randriamahazo et al. Evaluation of antigen-based rapid detection test for the diagnosis of SARS CoV-2 in low-income countries
Zhou et al. A preliminary study on analytical performance of serological assay for SARS-CoV-2 IgM/IgG and application in clinical practice
Lei et al. Different methods of COVID-19 detection
Parikh et al. Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic
Sidiq et al. Laboratory diagnosis of novel corona virus (2019-nCoV)-present and the future
Wang et al. Development of a SARS‐CoV‐2 rapid antibody detection kit and study on dynamic changes in antibodies in infected patients
Al-Alawi et al. Evaluation of four rapid antigen tests for detection of SARS-CoV-2 virus
Lapić et al. The reliability of SARS-CoV-2 IgG antibody testing–a pilot study in asymptomatic health care workers in a Croatian university hospital
Mannan et al. Detection of SARS-CoV-2 RNA by reverse transcription-polymerase chain reaction (RT-PCR) on self-collected nasal swab compared with professionally collected nasopharyngeal swab
Al-Ibraheemi et al. The relationship between IgG and IgM levels and severity of symptoms in COVID-19 patients confirmed by rapid antigen test
Dörschug et al. Evaluation of the Xiamen AmonMed Biotechnology rapid diagnostic test COVID-19 IgM/IgG test kit (Colloidal gold)